Tackling the increasing complexity of therapeutic monoclonal antibodies with mass spectrometry

被引:14
作者
Rosati, Sara [1 ,2 ,3 ]
Thompson, Natalie J. [1 ,2 ,3 ]
Heck, Albert J. R. [1 ,2 ,3 ]
机构
[1] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands
[2] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands
[3] Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands
关键词
Analytical method; Antibody (Ab); Antibody-drug conjugate (ADC); Biopharmaceutical; Biosimilar; Bispecific antibody; Glycosylation; Mass spectrometry; Native mass spectrometry; Sequence variant; FAB-ARM EXCHANGE; ELECTROSPRAY-IONIZATION; INTERACTION STRENGTH; INTACT ANTIBODIES; IGG; BIOPHARMACEUTICALS; GLYCOSYLATION; TECHNOLOGIES; BIOSIMILARS; GENERATION;
D O I
10.1016/j.trac.2013.02.013
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Mass spectrometry (MS) is emerging as an efficient method for the structural analysis of various new antibody-based therapeutic products. Here, we review the current trends and describe recent applications that highlight the use of MS to tackle the increasing complexity of monoclonal antibodies. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:72 / 80
页数:9
相关论文
共 58 条
  • [1] Antibody-drug conjugates: targeted drug delivery for cancer
    Alley, Stephen C.
    Okeley, Nicole M.
    Senter, Peter D.
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2010, 14 (04) : 529 - 537
  • [2] Resolving Disulfide Structural Isoforms of IgG2 Monoclonal Antibodies by Ion Mobility Mass Spectrometry
    Bagal, Dhanashri
    Valliere-Douglass, John F.
    Balland, Alain
    Schnier, Paul D.
    [J]. ANALYTICAL CHEMISTRY, 2010, 82 (16) : 6751 - 6755
  • [3] Beavis R C, 1989, Rapid Commun Mass Spectrom, V3, P436, DOI 10.1002/rcm.1290031208
  • [4] Beavis R C, 1989, Rapid Commun Mass Spectrom, V3, P432, DOI 10.1002/rcm.1290031207
  • [5] Beavis R C, 1989, Rapid Commun Mass Spectrom, V3, P233, DOI 10.1002/rcm.1290030708
  • [6] Characterization of Therapeutic Antibodies and Related Products
    Beck, Alain
    Wagner-Rousset, Elsa
    Ayoub, Daniel
    Van Dorsselaer, Alain
    Sanglier-Cianferani, Sarah
    [J]. ANALYTICAL CHEMISTRY, 2013, 85 (02) : 715 - 736
  • [7] Biosimilar, Biobetter, and Next Generation Antibody Characterization by Mass Spectrometry
    Beck, Alain
    Sanglier-Cianferani, Sarah
    Van Dorsselaer, Alain
    [J]. ANALYTICAL CHEMISTRY, 2012, 84 (11) : 4637 - 4646
  • [8] Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars
    Berkowitz, Steven A.
    Engen, John R.
    Mazzeo, Jeffrey R.
    Jones, Graham B.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (07) : 527 - 540
  • [9] Therapeutic antibodies for autoimmunity and inflammation
    Chan, Andrew C.
    Carter, Paul J.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2010, 10 (05) : 301 - 316
  • [10] Structural and functional characterization of the trifunctional antibody catumaxomab
    Chelius, Dirk
    Ruf, Peter
    Gruber, Patrick
    Ploescher, Matthias
    Liedtke, Reinhard
    Gansberger, Eva
    Hess, Juergen
    Wasiliu, Michael
    Lindhofer, Horst
    [J]. MABS, 2010, 2 (03) : 309 - 319